WilmerHale Reps Spring Bank Pharmaceuticals in IPO

  • 5.12.2016

WilmerHale represented Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, in its initial public offering.
The WilmerHale team on the transaction was led by Partner Stuart Falber and included Counsel Carolyn Rucci, Senior Associate Mia Kelley, and Associates Alyce Chen and Leah Segal.
For more information read Spring Bank's press release.